Topics
Glioblastoma | Treatment | Targeted therapy | Angiogenesis inhibitors | Observational studies
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Angiogenesis inhibitors > Observational studies
Nimotuzumab
Wu Y, Chen Z, Shi M, Qiu S, Zhang Y.
Nimotuzumab
and bevacizumab combined with
temozolomide and radiotherapy in patients with newly diagnosed
glioblastoma multiforme:
a retrospective single-arm study.
J
Neurooncol. 2025 Jan 6. doi:
10.1007/s11060-024-04932-8. PMID:
39760795. Observational study˰
ˍ